E. Coli Infection - Search News

FDA approves 1st new UTI drug in decades

FDA approves first new antibiotic for UTIs in nearly 30 years

The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the standard antibiotics.

The Independent on MSN · 1d

FDA approves new UTI antibiotic that may help patients with recurring infections

Blujepa, which is made by the British pharmaceutical company GSK plc, is approved for the treatment of women and children over the age of 12 with uncomplicated UTIs caused by bacteria including E. coli, Klebsiella pneumoniae, Citrobacter freundii complex, Enterococcus faecalis, and a type of staph infection known as Staphylococcus saprophyticus.

The Hill on MSN · 1d

FDA approves first new UTI drug in decades

The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug approved in decades and the first in a new class of medications. British

2don MSN

There’s a New Pill to Treat UTIs

On March 25, the U.S. Food and Drug Administration (FDA) approved the first new antibiotic to treat UTIs in 30 years. The ...

Food Safety News2d

Twelve E. coli cases under investigation in Latvia

Latvian public health officials have reported 12 recent E. coli infections with mostly children sick. The Center for Disease Prevention and Control (SPKC) ...

Al Día News1d

After 30 Years, a New Antibiotic for Urinary Tract Infections Arrives

The FDA has approved the drug for use in women and girls over the age of 12 who suffer from uncomplicated urinary tract ...

Fierce Pharma2d

GSK ushers in new UTI antibiotic with FDA nod for first-in-class Blujepa

GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...

News Medical on MSN4d

Bacteria Use Dormant Phages to "Vaccinate" Against Future Infections

Researchers at Johns Hopkins Medicine have shown that bacteria can create immunity by stealing genetic material from dormant ...

FDA Approves Blujepa for Uncomplicated Urinary Tract Infections

TUESDAY, March 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract infections (uUTIs) in adult women ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results